Investigators unveil the significance of PFN1 N6-methyladenosine modification in vascular smooth muscle cells, demonstrating its role in promoting phenotype switching and neointimal hyperplasia through the activation of the p-ANXA2/STAT3 pathway.
[Arteriosclerosis Thrombosis and Vascular Biology]